US$ 28.98
bimagrumab tirzepatide clinical trial What's next for weight-loss pharmacotherapies? A Study to Investigate Weight
Description
How do you mix Tirzepatide (a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist) 5mg powder with bacteriostatic 0.9% sodium chloride (NaCl) solution for a patient with type 2 diabetes?

[DOI] [PubMed] [Google Scholar] 3.World Health Organization
During this ramp-up period, side effects like nausea or fatigue can occur

JAMA Netw Open 8, e2457349 (2025)
